Analysis of the impact and burden of illness of adult chronic ITP in the US

References

• Woods VL Jr, Oh EH, Mason D, et al. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-75
   PubMed Web of Science ®Google Scholar
• Woods VL Jr, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984;64:156-60
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB, McMillan RB, et al. Congenital and acquired thrombocytopenia. Hematology (Am Soc Hematol Educ Program). Washington, DC: American Society of Hematology, 2004:390-406
   Google Scholar
• McMillan R, Durette C. Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 2004;104:956-60
   PubMed Web of Science ®Google Scholar
• Neylon AJ, Saunders PW, Howard MR, et al.on behalf of the Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003;122:966-74
   PubMed Web of Science ®Google Scholar
• Cines DB, Blanchette MB Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008
   PubMed Web of Science ®Google Scholar
• George JN Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 2006;4:1664-72
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-51
   PubMed Web of Science ®Google Scholar
• Provan A, Newland A. Idiopathic thrombocytopenic purpura in adults. J Pediatr Hematol Oncol 2003;25(Suppl 1):S34-8
   PubMedGoogle Scholar
• Portielje JEA, Westerndorp RGJ, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001;97:2549-54
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology. General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96
   PubMed Web of Science ®Google Scholar
• American Society of Hematology. ITP Practice Guideline Panel. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. Ann Intern Med 1997;126:319-26
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40
   PubMed Web of Science ®Google Scholar
• Segal JB, Powe NR Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006;4:2377-83
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-93
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 1998;30:38-44
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Fogarty PF, Segal JB The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007;14:515-19
   PubMed Web of Science ®Google Scholar
• Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal [comment on: Segal JB, Powe NR. In: J Thromb Haemost 2006;4:2377-83]. J Thromb Haemost 2008;6:711-12
   Google Scholar
• Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999;94:909-13
   PubMed Web of Science ®Google Scholar
• Diz-Kucukkaya R, Gushiken FC, Lopez JA. Thrombocytopenia. In: Lichtman MA, Beutler E, Kipps TJ, et al., eds. Williams Hematology, 7th edn. New York: McGraw-Hill, 2006:1749-83
   Google Scholar
• Weiss GB, Klock JC, Richardson HB Idiopathic thrombocytopenic purpura in the elderly. Lancet 1975;1:411-12
   PubMed Web of Science ®Google Scholar
• Shashaty GG, Rath CE Idiopathic thrombocytopenic purpura in the elderly. Am J Med Sci 1978;276:263-7
   PubMed Web of Science ®Google Scholar
• McMillan R, Bussel JB, George JN, et al. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 2008;83:150-4
   PubMed Web of Science ®Google Scholar
• Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000;160:1630-8
   PubMed Web of Science ®Google Scholar
• Rodeghiero F. Idiopathic thrombocytopenic purpura: an old disease revisited in the era of evidence-based medicine. Haematologica 2003;88:1081-7
   PubMed Web of Science ®Google Scholar
• Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the cooperative Latin American group on hemostasis and thrombosis. Blood 1984;64:1179-83
   PubMed Web of Science ®Google Scholar
• Janatpur K, Holland PV Noninfectious serious hazards of transfusion. Curr Hematol Rep 2002;1:149-55
   PubMedGoogle Scholar
• Langdale LA Infectious complications of blood transfusions. Infect Dis Clin North Am 1992;6:731-44
   PubMed Web of Science ®Google Scholar
• Zimmer J, Andrès E, Noel E, et al. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Clin Lab Haematol 2004;26:137-42
   PubMedGoogle Scholar